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Abstract
The introduction of a hydroxyl group “biohydroxylation” in the steroid skel-
eton is an important step in the synthesis of new steroids used physiologically as 
hormones and active drugs. There are currently about 300 known steroid drugs 
whose production constitutes the second category within the pharmaceutical 
market after antibiotics. Several biotransformations at industrial scale have been 
applied in the production of steroid hormones and drugs, which have functional-
ized different types of raw materials by means of chemo-, regio-, and stereoselec-
tive reactions (hydroxylation, Baeyer-Villiger oxidation, oxidation reactions, 
reduction of group carbonyl, isomerization, and Michael additions, condensa-
tion reactions, among others). In Green Chemistry, biotransformations are an 
important chemical methodology toward more sustainable industrial processes.
Keywords: biotransformation, steroid compounds, biological transformation, 
bioconversions, microorganisms
1. Introduction
Steroids (stereos = solids) are organic compounds derived from alcohols, which 
are widely distributed in the animal and plant kingdoms. Their base skeleton has 17 
carbon atoms in a tetracyclic ring system known as cyclopentanoperhydrophenan-
threnes (gonane and estrane). In this group of substances, life-vital compounds are 
categorized, such as cholesterol, bile acids, sex hormones, vitamin D, corticoste-
roids, cardiac aglycones, and antibiotics, among others.
Some of the most potent toxins are steroid alkaloids. Steroids are responsible for 
important biological functions in the cell; for example, the steroids derived from 
androstane, pregnane, and estrane have hormonal activity [1–5]; bile acids are 
important for the digestion and absorption of fats; and cardiotonic aglycones are 
used for the treatment of heart disease. Sterols are constituents of the cell mem-
brane, essential for cell stability and development; also, they are precursors of bile 
acids and steroid hormones.
A large number of steroids are used as anti-inflammatory agents [6], immu-
nosuppressants, progestational agents, diuretics, anabolics, and contraceptives 
[7–9]. Some are used for the treatment of prostate and breast cancer [10, 11], for 
adrenal insufficiency [12], for prevention of heart disease [13], as antifungal agents 
[14], and as active ingredients used for the treatment of obesity [15] and AIDS 
[16]. Recently, the antiviral activity against the herpes simplex virus type I of some 
steroid glycosides was determined [17].
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The therapeutic action of some steroid hormones has been associated with their 
interaction with intracellular receptors, which act as transcription factors in the 
regulation of gene expression [18]. It has been reported that some steroids, such 
as dehydroepiandrosterone (DHEA), progesterone, pregnenolone and its sulfated 
derivatives [19, 20], as well as, 17β-estradiol, allopregnanolone and its synthetic 
derivatives (afoxolaner and ganaxolone) are considered neurosteroids, due to their 
action at the level of the CNS [19].
The physiological activity of steroids depends on their structure, the type, 
number, spatial orientation, and reactivity of the different functional groups pres-
ent in the tetracyclic core as well as the oxidation state of the rings. For example, the 
presence of an oxygenated function in C-11β is crucial for the anti-inflammatory 
activity; the hydroxyl function in C-17β determines androgenic properties; the 
aromatization of ring A confers estrogenic effect; and corticosteroids have the 
3-keto-4-ene group and the pregnane side chain at C-17 [21, 22].
Currently, about 300 steroid drugs are known, and this number tends to grow. 
Their production represents the second category in the pharmaceutical market 
after antibiotics [24, 25]. Nowadays, steroids represent one of the largest sectors in 
pharmaceutical industry with world markets in the region of US$ 10 billion and the 
production exceeding 1,000,000 tons per year [23].
The production of steroid drugs and hormones is one of the best examples 
of the applications that biotransformations have on an industrial scale [3, 21]. 
Microbiological transformations are an effective tool for the preparation of various 
compounds [26], which can be difficult to obtain by conventional chemical methods 
and have been widely used in the bioconversion of steroids [25]. In 1950, the pharma-
cological effects of cortisol and progesterone were reported, in addition to the hydrox-
ylation of the latter in C-11α using Rhizopus species. This began a very important stage 
in the development of the synthesis of steroids with biological activity [4, 5].
Currently, a great versatility of microbial systems in the pharmaceutical indus-
try for the commercial production of steroids and other drugs is recognized [27, 28]. 
Several hundreds of microbiological transformations of steroids have been reported 
in the literature; also, many bioconversions have been incorporated into numer-
ous partial syntheses of new compounds for their evaluation such as hormones or 
drugs [21, 29–32]. Chemical derivatives of some steroids are reported to have better 
therapeutic advantages than the starting materials.
However, the main objectives in the research and development of the steroid 
drug industry currently consist of the detection and isolation of microbial strains 
with novel activity or more efficient transformation capacity, where genetic engi-
neering and metabolic engineering can play a prominent role in the metabolism of 
bacteria, fungi, and plants [33–36].
The aim of the present review is to emphasize the importance of biotransforma-
tion using microorganisms to obtain steroid compounds with pharmaceutical inter-
est, as a chemical-biological strategy that alternates with the chemical synthesis, 
and to highlight the chemical reaction made by different types of microorganisms in 
the functionalization of the steroid skeleton.
2. Microbiological transformations of steroids
In Green Chemistry, biotransformations constitute an important methodology in 
organic chemistry [37]. The microbiological transformations of steroids have been 
an essential chemical tool used for the preparation of many intermediaries and in the 
generation of new drugs, where chemical functionalization-hydroxylation, Baeyer-
Villiger oxidation, reduction, isomerization, Michael additions, and condensation 
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reactions can be carried out in different positions of the steroid skeleton in chemo-, 
regio-, and stereoselective ways, being very complicated or even impossible by the 
classic chemical methods. Currently, any stereogenic center of the steroid skeleton 
can be specifically hydroxylated stereoselectively. Nowadays, biohydroxylations in 
C-11α, 11β, 15α, and 16α are industrially carried out via a microbial hydroxylation 
with good yields and enantiomeric excess (ee). Below are some of the microbiologi-
cal transformations performed on different natural and synthetic steroids [25].
In the literature, it is the well-documented regio- and stereoselective hydroxyl-
ation in C-14 with α orientation in progesterone (1) and other steroids by well-func-
tioning fungi, such as Thamnostylum piriforme (ATCC 8992), Mucor griseocyanus 
(ATCC 1207a), Actinomucor elegans (MMP 3132), and Zygodesmus sp. (ATCC 14716).
From the incubation of 1 with T. piriforme, 14α-hydroxyprogesterone (2, 32%) 
and 9α-hydroxyprogesterone (3, 1.4%) were obtained; whereas in the incubation 
of 1 with M. griseocyanus, 2 (13.4%), 7α,14α-dihydroxyprogesterone (4, 6.5%) 
and 6β,14α-dihydroxyprogesterone (5, 2.8%) were obtained. In the biotrans-
formation of 1 using A. fumigatus after 24 h of incubation, different mono-and 
dihydroxylated products were obtained: 11α-hydroxyprogesterone (6, 33%), 
11α,15β-dihydroxyprogesterone (7, 17%), 7β,15β-dihydroxyprogesterone (8, 14%), 
15β-hydroxyprogesterone (9), 7β-hydroxyprogesterone (10), where 9 and 10 were 
detected in minimal quantity. Finally, at 72 h, the main products were 7 (48%) and 
8 (25%), with the positions 11α and 15β being hydroxylated more easily than the 
position 7β in 1 [38, 39].
In the incubation of 1 with Saprolegnia hypogyna, 4-androstene-3,17-dione 
(11), testosterone (12), and testolactone (13) were obtained [40]. The compounds 
13 (98%) were also obtained from the bioconversion of 1 using A. sojae (PTCC 
5196). The biotransformation pathway indicating the presence of Baeyer-Villiger 
monooxygenase (BVMO) can carry out both oxygenative esterification of 20-keto-
steroids and oxygenative lactonization of 17-ketosteroids [41]. The compounds 
15α-hydroxyprogesterone (14, 47%) and 12β,15α-dihydroxyprogesterone (15, 25%) 
were isolated in the biotransformation of 1 using Fusarium culmorum [42]. In the 
biotransformation of 1 using the bacterium, thermophilic Bacillus stearothermophi-
lus, four products of monohydroxylation, 20α-hydroxyprogesterone (16, 61%), 
6β-hydroxyprogesterone (17, 21%) and 6α-hydroxyprogesterone (18, 14%), and 
9,10-seco-pregnen-3,9,20-trione (19, 4%), were isolated [43].
An efficient regio- and stereoselectivity was observed in the biotransforma-
tion of 1 on a large scale by the system Mucor 881 (M881) to give the hydroxylated 
derivatives 6, 6β,11α-dihydroxyprogesterone (20), and 6β-hydroxypregn-4-ene-
3,11,20-trione (21). In the literature, it is described that species of the genus Mucor 
and Rhizopus can hydroxylate said positions but with lower yields. The fungal 
system M881 showed the ability to carry out hydroxylation at 6β and 11α positions 
of 4-ene-3-one steroids (1, 11, 12 and 211) [44].
Recently, it was reported that in the biotransformation of 1 using Penicillium 
aurantiogriseum for 10 days, 11 and androsta-1.4-dien-3,17-dione (22) were obtained. 
These products were observed in the biotransformation of 1 using Bacillus sphaericus; 
the hydroxylation in C-17 was mainly observed [45, 46]. Biotransformation of 1 
using Geobacillus gargensis (DSM 15378) has resulted in the production of secoderiva-
tives: 19 and 23 (9,10-seco-4-pregnene-20α-hydroxy-3,9-dione), which are produced 
by the rupture of the ring B of 1 (Figure 1) [47]. Secosteroids are an important 
group, which exhibits a variety of different biological activities [48, 49].
In the biotransformation of 5β-dihydroprogesterone (24) using T. piriformis, 
14α-hydroxy-5β-pregnan-3,20-dione (25, 11.8%), 3β,14α-dihydroxy-5β-pregnan-20-
one (26, 0.5%), and 14α,15β-dihydroxy-5β-pregnan-3,20-dione (27, 0.4%) were char-
acterized, while in the biotransformation of 3β-hydroxy-5β-pregnan-20-one (28), 26 
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(0.6%) and 3β,9α,14α-trihydroxy-5β-pregnan-20-one (29, 16%) were isolated, after 
being incubated for 96 h. The microbiological transformation of 28 using Actinomucor 
elegans produced the compounds 25 and 28 in lower yield than T. piriforme and a minor 
product identified as 3β,9α-dihydroxy-5α-pregnan-20-one (30) (Figure 2) [38].
The biotransformation of 16-dehydroprogesterone (4,16-pregnadien-3,20-dione, 
31) using Mucor piriformis has been reported to give different hydroxylation products: 
14α-hydroxypregna-4,16-dien-3,20-dione (32, 1%), 7α,14α-dihydroxypregna-4,16-
dien-3,20-dione (33, 78%), 3β,7α,14α-trihydroxy-5α-pregna-16-en-20-one (34, 3%), 
and 3α,7α,14α-trihydroxy-5α-pregna-16-en-20-one (35, 2%); while the microsomes 
Figure 1. 
Biotransformation products of progesterone (1).
Figure 2. 
Biotransformation products of 5β-dihydroprogesterone (24).
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prepared from 31 transformed the hydroxylate to 14α-hydroxy derivative (32). 
Incubation of 32 with M. piriformis resulted in the formation of 33–35 (Figure 3) [50].
In contrast, in the biotransformation of 17α-hydroxyprogesterone (36) using 
M. piriformis, after 48 h of incubation, four compounds were obtained: 17α,20α-
dihydroxypregn-4-en-3-one (37, 19%), 7α,17α-dihydroxypregn-4-en-3,20-dione 
(38, 25%), 6β,17α,20α-trihydroxy-pregn-4-en-3-one (39, 18%), and 11α,17α,20α-
trihydroxypregn-4-en-3-one (40, 25%); it was observed that M. piriformis was able 
to hydroxylate the C-6, C-7, C-11, and C-14 positions stereospecifically, in addition 
to reducing the 4-en-3-one system in ring A and the keto group of C-20 (Figure 4) 
[50]. The biotransformation of 36 using Fusarium culmorum led to the formation of 
14 (47%) and 15 (25%) [42].
Pregnenolone (3β-hydroxypregn-5-en-20-one, 41), the precursor of many ste-
roid hormones, was biotransformed by Mucor piriformis to obtain two metabolites, 
3β,7α-dihydroxypregn-5-en-20-one (42) and 3β,7α,11α-trihydroxypregn-5-en-
20-one (43) [51], where 43 (46.4%) was also a bioconversion product of 41 using 
Mucor circinelloides var. lusitanicus [52]. Two metabolites of pregnenolone (41) 
obtained from biotransformation of B. cinereae were characterized as 3β,11α,16β-
trihydroxypregn-5-en-20-one (44, 39%) and 11α,16β-dihydroxypregn-4-en-3,20-
dione (45, 6%). The formation of the hydroxylation products in C-11 and C-16 by 
B. cinereae can be determined by the presence of the acetyl group in C-20 [53]. The 
biotransformation of 41 using different microorganisms (Cunninghamella elegans, 
R. stolonifer, and G. fujikuroi) was reported by Choudhary et al. [54]. Incubation of 
41 with C. elegans produced 3β,7β,11α-trihydroxypregn-5-en-20-one (46, 28%), 
3β,6α,11α,12β,15β-pentahydroxypregn-4-en-20-one (47, 4%), and 3β,6β,11α-
trihydroxypregn-4-en-20-one (48, 2%), while incubation with G. fujikuroi, two 
products 3β,7β-dihydroxypregn-5-en-20-one (49, 3%) and 6β,15β-dihydroxypregn-
4-en-3,20-dione (50, 2%) were obtained. In the microbiological transformation of 
41 using different Bacillus strains, 42, 49, and 7-oxo-pregnenolone (51) were the 
major products obtained [55], while by using Fusarium oxysporum var. cubense, 42 
was the only product obtained [56]. The biotransformation of pregnenolone acetate 
(52) using C. elegans generated 41, 22, 6β,15β-dihydroxyandrosta-4-en-3,17-dione 
(53), and 11α,15β-dihydroxypregn-4-en-3,20-dione (54), while by using R. stoloni-
fer, 11α-hydroxypregn-4-en-3,20-dione (55) and 53 were obtained (Figure5) [54].
The microbiological transformation of the racemic mixture of 13-ethyl-17β-
hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one (56) was tested with different fungi 
Rhizopus nigricans, R. arrhizus, Aspergillus niger, A. ochraceus, and Curvularia lunata. 
The bioconversion of the racemic mixture of 53 by R. arrhizus produced only one major 
product, (±)-13-ethyl-10β,17β-dihydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one 
Figure 3. 
Biotransformation products of 16-dehydroprogesterone (31).
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(57, 28.4%), whereas R. nigricans, A. niger, and C. lunata biotransformed 56 to 57 more 
slowly and inefficiently [57].
The racemic mixture (±)-13-ethyl-7β,17β-dihydroxy-18,19-dinor-17α-pregn-
4-en-20-yn-3-one (58, 4.3%) was obtained as product of incubating mixture 
56 with A. ochraceus; none of the fungi tested were able to differentiate the two 
enantiomers of 56 in the course of the hydroxylation reaction; in addition, the 
absence of the hydroxylated derivative in C-11 is due to the presence of the ethyl 
group in C-13 or the ethynyl group in C-17 [57]. The microbiological transforma-
tion of the racemic mixture and the dextro enantiomer of compound 56 has been 
described using different species of Cunninghamella [58]. For example, the trans-
formation of the racemic mixture of 56 by C. blakesleeana (AS 3.910) produced 
57 (5.3%), 13-ethyl-6β,17β-dihydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one 
(59, 3.6%), 13-ethyl-15α,17β-dihydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one 
(60, 3.0%), and 13-ethyl-6β,10β,17β-trihydroxy-18,19-dinor-17α-pregn-4-en-
20-yn-3-one (61, 3.6%), while by using C. echinulata (AS 3.1990), 61 (3.2%), 57 
(1.2%), and enantiomer dextro of 58 (2.9%) were obtained. The transformation of 
the enantiomer dextro of 56 using C. blakesleeana produced 57 (1.2%), 58 (2.9%), 
and 61 (3.2%), by using C. echinulata, the same compounds were obtained but in 
lower yield. Therefore, the microbial transformation of the racemic mixture and the 
d-enantiomer of 56 using different Cunninghamella species gave poor yields and poor 
resolutions, which were obtained for the hydroxylation reaction (Figure 6) [58].
Figure 4. 
Biotransformation products of 17α-hydroxyprogesterone (36).
Figure 5. 
Biotransformation products of pregnenolone (41) and acetyl derivate (52).
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The biotransformation of danazol (17β-hydroxy-17α-pregna-2,4-dien-20-
yno-[2,3-d]-isoxazole, 62), a heterocyclic steroid drug in which an isoxazole 
ring is fused with ring-A of a steroid nucleus, using Fusarium lini, A. niger and 
Cephalosporium aphidicola yielded 17β-hydroxy-2-(hydroxymethyl)-17α-pregn-4-
en-20-yn-3-one (63) and 17β-hydroxy-2-(hydroxymethyl)-17α-pregn-1,4-dien-20-
yn-3-one (64); while Bacillus cereus afforded 64, as the only product [59]. Microbial 
transformation of danazol (62) using C. blakesleeana yielded four compounds: 
14β,17β-dihydroxy-2-(hydroxymethyl)-17α-pregn-4-en-20-yn-3-one (65, 1.2%), 
1α,17β-dihydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole (66, 1.2%), and 
6β,7β-dihydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole (67, 0.8%) and 64 
(1.2%). This involves hydroxilations al C-1, C-6 and C-15, whereas oxidation at C-3, 
and N-O bond cleavage has also occurred (Figure 7) [60].
Norethisterone (17α-ethynyl-19-nortesterone, 68) is a potent progestin used as 
a contraceptive agent; its biotransformation with Cephalosporium aphidicola (IMI 
68689) produced the aromatization of ring A that yielded 17α-ethynylestradiol 
(69), whereas 69 was biotransformed by Cunninghamella elegans (NRRL 
1392) producing the compounds 19-nor-17α-pregna-1,3,5(10)-trien-20-yn-
3,4,17β-triol (70), 19-nor-17α-pregna-1,3,5(10)-trien-20-yn-3,7α,17β-triol (71), 
19-nor-17α-pregna-1,3,5(10)-trien-20-yn-3,11α,17β-triol (72), 19-nor-17α-
pregna-1,3,5(10)-trien-20-yn-3,6β,17β-triol (73), and 19-nor-17α-pregna-1,3,5(10)-
trien-20-yn-3,17β-diol-6β-methoxy (74) (Figure 8) [61].
Mestranol (75) and 17β-methoxymestranol (76) are the mono- and dialkylated 
derivatives of 69, respectively. In incubating 75 with C. elegans, two hydroxyl-
ated compounds were obtained: 6β-hydroxymestranol (77, 2.8%) and 6β,12β-
dihydroxymestranol (78, 3.6%), inferring that the presence of the methoxyl group 
in C-3 reduces the number of biotransformation products and introduces hydroxyl 
groups in C-6 and C-12 with β orientation, while 76 was not biotransformed due to 
the presence of the methoxyl group in C-17 (Figure 9) [62].
Microbial transformation of 6-dehydroprogesterone (79) using A. niger yielded 
five metabolites: 6β-chloro-7α,11α-dihydroxypregna-4-en-3,20-dione (80, 1.0%), 
7α-chloro-6β,11α-dihydroxypregna-4-en-3,20-dione (81, 1.33%), 6α,7α,-epoxy-11α-
hydroxypregna-4-en-3,20-dione (82, 1.33%), 6α,7α,-epoxy-pregna-4-en-3,20-dione 
(83, 2.0%), and 11α-hydroxypregna-4,6-dien-3,20-dione (84, 2.33%). Compound 
11α-hydroxyandrosta-4,6-dien-3-one (85, 15.4%) was obtained through whole cell 
biotransformation of 79 by G. fujikuroi (ATCC 10704). The formation of 80 and 81 
is an interesting finding. This route provides an efficient method for the obtention 
of chlorohydrins from alkene functionality [63]. The compound 84 was obtained 
through the microbial transformation of 79 using R. nigricans [64], Nigrospora 
sphaerica, Mucor racemosus, and Botryosphaeria obtusa. 6-dehydroprogesterone (79) 
Figure 6. 
Biotransformation products of (+)-13-ethyl-17β-hydroxy-18, 19-dinor-17α-pregn-4-en-20-yn-3-ona (56).
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is a synthetic derivate of progesterone. Botryodiplodia theobromae was used for the 
synthesis of 6-DPH from progesterone (Figure 10) [65].
Incubation of melengestrol acetate (86) with C. blakesleeana, which provides 
an route for the monohydroxylation of the (86) at C-11, yielded a 17α-acetoxy-11β-
hydroxy-6-methylenepregna-4,6-diene-3,20-dione (87) (Figure 11) [66].
Biotransformation of 3β-hydroxy-17β-carboxyethyl-5β-
androstenol (88) using T. pyriformis resulted in the mixture of 
Figure 9. 
Biotransformation of products of mestranol (75).
Figure 7. 
Biotransformation products of danzol (62)
Figure 8. 
Biotransformation products of norethisterone (68) and 17α-ethinylestradiol (69).
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Figure 10. 
Biotransformation products of 6-dehydroprogesterone (79).
Figure 11. 
Biotransformation products of melengestrol acetate (86).
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3β,14α-dihydroxy-17β-carboxyethyl-5β-androstenol (89, 9%) with 9α,14α-
dihydroxy derivative (90, 12%) and two minor products 14α,15α-dihydroxy (91) 
and 15β-hydroxy (92). Compound 92 was identified as a product of biotransforma-
tion using A. elegans, M. griseocyamus, and Zygodesmus sp. (Figure 12) [38].
Androst-4-en-3,17-dione (11), which plays an important role in the metabolism 
of drugs, among many other functions, was biotransformed using M. piriformis to 
give one main product, 6β-hydroxyandrost-4-en-3,17-dione (93, 13%), and four 
minor products, 14α-hydroxyandrost-4-en-3,17-dione (94, 2%), 7α-hydroxyandrost-
4-en-3,17-dione (95, 2%), testosterone (12, 3%), and 6β-hydroxytestosterone (96, 
1%). In the biotransformation of 11 using M. griseocyamus 94 (9%), 95 (4%) and 
14α-hydroxytestosterone (97, 9%) were the major products obtained; likewise, 11 
and 93 were identified in the mixture of biotransformation products [67]. From 
the incubation of 11 with M. piriformis, 94–97 and 7α,14α-dihydroxytestosterone 
(98) were obtained [38]. Hydroxylated steroids in C-9 are important intermediaries 
in the synthesis of highly effective anti-inflammatory drugs. The microbiological 
transformation of 11 to 9α-hydroxyandrost-4-en-3,17-dione (99) was studied using 
Rhodococcus sp. in a low-nutrient culture medium at a fixed pH (Figure 13) [68]. 
When 11 was incubated with Bacillus strain HA-V6–3, the metabolites 12, 93–97, 
Figure 13. 
Biotransformation products of androst-4-en-3, 17-diona (11).
Figure 12. 
Biotransformation products of 3β-17β-carboxyethyl-5β-androsteno (88).
11
Biotransformation of Steroids Using Different Microorganisms
DOI: http://dx.doi.org/10.5772/intechopen.85849
6β,14α-dihydroxyandrost-4-en-3,17-dione (100), 11α-hydroxyandrost-4-en-3,17-
dione (101), androst-4-en-3,6,17-trione (102), and 5α-androst-3,6,17-trione (103) 
were produced as described by Schaaaf and Dettner [69].
In the bioconversion of 11 using C. aphidicola, 93 and 94 were obtained 
[70], while in the fermentation of 11 using Curvularia lunata, the products 101 
(4%), 17β-hydroxyandrost-1,4-dien-3-one (104, 4.4%), androsta-1,4-dien-
3,17-dione (105, 3%), 11α,17β-dihydroxyandrost-4-en-3-one (106, 4%), and 107 
(15α-hydroxyandrost-1,4-dien-3,17-dione, 2.8%) were obtained (Figure 13) [71]. 
Biotransformation of 11 using Beauveria bassiana was studied in times and with cul-
ture media at different pH (pH 6 and 7) [72]. At pH 6, two products were obtained: 
106 and 6β,11α-dihydroxyandrost-4-en-3,17-dione (108), where the stereoselective 
hydroxylation was observed at C-11α and C-6β; while at pH 7, the compounds 12, 
106, 3α,11α,17β-trihydroxy-5α-androstane (109), and 6β,11α,17β-trihydroxy-
androst-4-en-3-one (110) were obtained. Products 93 (14%) and 94 (75%) were 
isolated from the biotransformation of 11 using Chaetomium sp. (Figure 13) [73].
Obtaining hydroxylated derivatives in a specific position is one of the objectives 
of the steroid industry; for example, 14α-hydroxysteroids are shown to have anti-
inflammatory, contraceptive, and antitumor activities. With the biotransformation 
of 11 and 105 using different strains of the fungus, C. lunata allowed in the case of 
11, the production of a major product, 94; while with 105, 14α-hydroxyandrost-1,4-
dien-3,17-dione (111, 70%) was obtained (Figure 13) [74].
Androsta-1,4-dien-3,17-dione (105) is a useful precursor in the chemical or 
microbiological preparation of other steroid hormones and pharmaceutical. 
Transformation of 105 by Colletotrichum lini (As3.486) produced the hydroxyl-
ated compounds at C-11α and C-15α: 15α-hydroxyandrost-1,4-dien-3,17-dione 
(107), 11α,15α-dihydroxyandrost-1,4-dien-3,17-dione (112), and 15α,17β-
dihydroxyandrost-1,4-dien-3-one (113) (Figure 14) [75].
Testosterone (12) was metabolized by M. griseocyamus and T. piriforme. In 
the biotransformation of 12 using M. griseocyamus, 97 (35%) and other products 
were obtained, where 94 was identified as the major product. Conversely, the 
microbiological transformation of 12 using T. piriforme produced 97 (10%), as the 
main product at 24 h; after 72 h of biotransformation, four products were obtained: 
93 (13%), 96 (7%), 97 (13%), and 111 (5%). It was discovered that T. piriforme 
produced smaller quantity of 14α-hydroxy derivatives (Figure 15) [38].
In the biotransformation of 12 using Nectria haematococca, four substances were 
isolated, whose performance was dependent on the incubation time; majority of 
the products were produced at 72 h. The hydroxylated derivatives in C-11 with α 
Figure 14. 
Biotransformation products of androsta-1,4-dien-3, 17-dione (105).
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orientation and dehydrogenation in C1-C2 resulted in the following compounds: 
11α-hydroxyandrost-1,4-dien-3,17-dione (114, 8.0%), 11α,17β-dihydroxyandrost-
1,4-dien-3-one (115, 4.3%), 101 (1.9%), and 104 (2.3%) [76]. Incubation of 12 with 
Fusarium culmorum produced 93 (10%) and 96 (32%) with hydroxylated derivatives 
at C-6β, including the products, 15α,17β-dihydroxyandrost-4-en-3-one (116, 22%) 
and 15α-hydroxyandrost-4-en-3,17-dione (117). Selective hydroxylation of 103 at C-6 
with a β orientation and allylic position at the unsaturated 3-keto-system is favored 
by the system π and the presence of the hydroxyl group at C-17, while hydroxylation 
at C-15 is a very frequent process carried out by fungi of the genus Fusarium [42]. 
Metabolites 11, 85, 105, and 115 were obtained as oxidation and hydroxylation 
products of 12 using the fungus F. oxysporum var. cubense [56]. The fungus, 
Cephalosporium aphidicola, was hydroxylated with 12 to give the products 96 (47%) 
and 97 (3%), with hydroxylated derivatives in C-6β and C-14α, respectively [70]. 
Incubation of 12 with C. lunata and Pleurotus ostreatus yielded compounds 11 (17%) 
and 115 (13%), respectively [77]. The phytopathogenic fungus, Botrytis cinerea, 
produced 7β,17β-dihydroxyandrost-3-one (118, 73%), as the only biotransformation 
product of 12. It seems that the presence of the hydroxyl group in C-17 in the andro-
stane skeleton directed the hydroxylation at C-7 with a β orientation (Figure 15) [53].
In the biotransformation of 12 using Bacillus stearothermophilus, thermophilic 
bacterium, the major product obtained was 11 (90.2%); it was generated by the 
oxidation of C-17, and the hydroxylated derivatives of 11 in C-6 (93, C-6β, 1.1%) and 
(119, C-6α, 0.9%) include two monohydroxy derivatives of 12, 96 (C-6β, 3.9%) and 
120 (C-6α, 3.9%). This indicates that hydroxylation with α orientation in C-6 may be 
a common action of some thermophilic bacteria [78]. Biotransformation of 11 using 
B. stearothermophilus in the presence of hydrolase inducers—salicylic acid, chlor-
amphenicol, cyclodextrin, dexamethasone, riboflavin, and rifampicin—resulted in 
obtaining a higher concentration of the compounds: 9,10-seco-4-androst-3,9,17-tri-
one (121), 5α-androst-3,6,17-trione (103), 17β-hydroxy-5α-androst-3,6-dione (122), 
3β,17β-dihydroxyandrost-4-en-6-one (123), and 17β-hydroxyandrost-4,6-dien-3-one 
Figure 15. 
Biotransformation products of testosterone (12).
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(124). For example, the presence of glucose and cycloheximide favored the obtaining 
of 123, while the production of 124 was achieved in the presence of rifampicin [79]. 
The products isolated from the biotransformation of 12 using Chaetomium sp. were 
93 (21%), 94 (39%), and 99 (19%); after 24 h of incubation, the presence of 11 was 
detected. Janeczko et al. [73] concluded that the steric factors associated with the 
substrate determine the location and orientation of the hydroxyl group. For example, 
the carbonyl group in C-17 at 11 directs the entry of the hydroxyl group at C-14 
with α orientation, while the hydroxylation in C-6β is favored by the presence of the 
hydroxyl group in C-17, as in 12. In the case of progesterone (1), which has an acyl 
group, dihydroxylated derivatives were observed in C-6 and C-14 (Figure 15) [73].
Incubation of 11 and 12 with C. lini ST-1 displayed different catalytic character-
istics. Biotransformation of 11 afforded two products: 15α-hydroxyandrost-4-en-
3,17-dione (117, 5%) and 11α,15α-dihydroxyandrost-4-en-3,17-dione (125, 64%), 
while 12 yielded 15α-hydroxyandrost-4-en-3,17-dione (117, 60%). Incubation of 1 
resulted in the isolation of 14. Wu et al. [80] concluded that the different hydroxyl-
ation sites between 11 and 12 suggested that the hydroxyl group or carbonyl group 
on the substrate at C-17 had influence on the location of introduced hydroxyl groups 
(Figure 15).
Dehydroepiandrosterone (3β-hydroxyandrost-5-en-17-one, 126) endogenous 
prohormone secreted by the adrenal glands is a precursor of androgens and 
estrogens. Incubation with M. piriformis allowed the isolation of five compounds: 
3β,17β-dihydroxyandrost-5-ene (127), 3β,7α-dihydroxyandrost-5-en-17-one (128), 
3β-hydroxyandrost-5-en-7,17-dione (129), 3β,17β-dihydroxyandrost-5-en-7-one 
(130), and 3β,7α,17β-trihydroxyandrost-5-ene (131). The action of the fungus was 
the stereospecific hydroxylated products at C-7α (128 and 131) and the reduction 
of the carbonyl group at C-17 [51]. From the microbiological transformation of 
126 using Rhizopus stolonifer, six poducts  were isolated: 127 (20%), 128 (12%), 
129 (20%), 3β,17β-dihydroxyandrost-4-ene (132, 12%), 17β-hydroxyandrost-4-
en-3-one (133, 34%), and 3β,11β-dihydroxyandrost-4-en-17-one (134, 15%) [81]. 
Fusarium oxysporum biotransformed to 126 in a mixture of four hydroxylated 
derivatives (127–129 and 130), which were characterized as their acetylated deriva-
tives; the hydroxylation was favorably in C-7 stereospecifically (α orientation) in 
the 3β-hydroxy-Δ5-steroids, while Colletotrichum musae biotransformed to 126–127 
by reducing the carbonyl group in C-17 (Figure 16) [56].
Figure 16. 
Biotransformation products of dehydroepiandrosterone (126).
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In the biotransformation of 126 using Penicillium griseopurpureum and  
P. glabrum, the following was produced; hydroxylated derivatives in C-7α (95), 
C-14α (94) and C-15α (117), with 11 being the main product. In addition, P. griseo-
purpureum generated products for the Baeyer Villiger oxidation to give the lactone 
D ring (testolactone, 13) and its hydroxylated derivative at C-15α (15α-hydroxy-
17α-oxa-d-homo-androst-4-en-3,17-dione, 135); while P. glabrum generated 
the compounds, 3β-hydroxy-17α-oxa-D-homo-androst-5-en-17-one (136) and 
3β-hydroxy-17α-oxa-D-homo-5α-androstan-17-one (137) (Figure 16) [82].
The biotransformation of 17α-ethynyl-17β-hydroxyandrost-4-en-3-one (ethis-
terone, 138) and 17α-ethyl-17β-hydroxyandrost-4-en-3-one (139) was described 
using the fungi Cephalosporium aphidicola and Cunninghamella elegans. The 
bioconversion of 138 using C. aphidicola yielded 17α-ethynyl-17β-hydroxyandrost-
1,4-dien-3-one (140, 5.5%), while by using C. elegans, 17α-ethynyl-11α,17β-
dihydroxyandrost-4-en-3-one (141, 3.4%) was obtained. The biotransformation of 
138 using C. aphidicola generated 17α-ethyl-17β-hydroxyandrost-1,4-dien-3-one 
(142, 2.2%). In contrast, when incubating 139 with C. elegans, two new products 
were obtained: 17α-ethyl-11α,17β-dihydroxyandrost-4-en-3-one (143, 2.8%) and 
17α-ethyl-6α,17β-dihydroxy-5α-androstan-3-one (144, 1.6%) (Figure 17) [83].
Adrenosterone (145) is an inhibitor of the enzyme estrogen synthetase responsible 
for the formation of estrogen, and it has a great clinical application. Biotransformation 
of 145 using C. aphidicola produced androst-1,4-dien-3,11,17-trione (146, 3%), 
17β-hydroxyandrost-4-en-3,11-dione (147, 2%), and 17β-hydroxyandrost-1,4-dien-
3,11-dione (148, 17%). 145 (11.2%) and 12 (8.1%) were obtained from the biotrans-
formation of 145 using Fusarium lini, while 147 (36.8%) was obtained from the 
biotransformation of 145 using Trichothecium roseum (Figure 18) [84].
The biotransformation of mesterolone (1α-methyl-17β-hydroxy-5α-androst-3-
one, 149), a synthetic androgenic steroid, was performed using different fungi as 
described by Choudhary et al. [85]. From the biotransformation of 149 using C. 
aphidicola, the compounds 1α-methyl-5α-androst-3,17-dione (150), 1α-methyl-5α-
androst-3,17-diol (151), and 1α-methyl-15α-hydroxy-5α-androst-3,17-dione (152) 
were obtained. Incubation of 149 with Fusarium lini produced the compounds 
152, 1-methyl-5α-androst-1-en-3,17-dione (153), 1α-methyl-6α,17β-dihydroxy-5α-
androst-3-one (154), 1α-methyl-15α,17β-dihydroxy-5α-androst-3-one (155), and 
1-methyl-15α,17β-dihydroxy-5α-androst-1-en-3-one (156). The products obtained 
from the biotransformation of 149 using R. stolonifer were 150, 154, 156, 1α-methyl-
7α,17β-dihydroxy-5α-androst-3-one (157), and 1α-methyl-11α,17β-dihydroxy-5α-
androst-3-one (158) [85]. Bioconversion of 149 using C. blakesleeana produced 
Figure 17. 
Biotransformation products of 17α-ethynyl-17β-hydroxyandrost-4-en-3-one (138) and 17α-ethyl-17β-
hydroxyandrost-4-en-3-one (139).
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seven biotransformation products, such as 154, 157, 158, in addition to 1α-methyl-
1β,11β,17β-trihydroxy-5α-androst-3-one (159), 1α-methyl-7α,11β,17β-trihydroxy-
5α-androst-3-one (160), 1α-methyl-1β,6α,17β-trihydroxy-5α-androst-3-one (161), 
and 1α-methyl-1β,11α,17β-trihydroxy-5α-androst-3-ona (162). Macrophomina pha-
seolina biotransformed 149 to obtain 1α-methyl-17β-hydroxy-5α-androst-3,6-dione 
(155) [86]. Additionally, the biotransformation of 141 using C. blakesleeana (ATCC 
8688A) yielded three metabolites: 1α-methyl-11β,14α,17β-trihydroxy-5α-androstan-
3-one (163, 0.4%), 1α-methyl-7β,17β-dihydroxy-5α-androstan-3-one (164, 0.47%), 
and 1α-methyl-17β-hydroxy-5α-androstan-3,7-dione (165, 0.67%). C. blakesleeana 
catalyzed the β-hydroxylation in C-11, and dihydroxylation and oxidations at vari-
ous positions of steroid skeleton (Figure 19) [87].
In the microbiological transformation of 3-hydroxyestra-1,3,5-(10)-trien-
17-one (166) using Fusarium oxysporum var. cubense, the compounds, reduced 
in C-17 (3,17-dihydroxyestra-1,3,5-(10)-triene, 167) and hydroxylated in C-15 
(3,15α-dihydroxiestra-1,3,5-(10)-triene, 168), were isolated (Figure 20) [56].
Prednisone (169) is a synthetic corticosteroid (prodrug) used for the treat-
ment of autoimmune, inflammatory and kidney diseases, among others. 
Figure 18. 
Biotransformation products of andresterone (145).
Figure 19. 
Biotransformation products of mesterelone (149).
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Biotransformation of 169 using C. elegans occurred by hydrogenation of the Δ4(5) 
and reduction of C-20, to produce the compounds 17α,21-dihydroxy-5α-pregn-
1-en-3,11,20-trione (170, 15.6%) and 17α,(20S),21-trihydroxy-5α-pregn-1-en-
3,11-dione (171, 6.5%); whereas as the only biotransformation product, 169 using 
F. lini (5.2%), R. stolonifer (5.5%) and C. lunata (6.2%), was 1,4-pregnadien-
17α,(20S),21-trihydroxy-3,11-dione (172) (Figure 21) [88].
The main chemical transformation carried out by different Acremonium spe-
cies in various steroid compounds have been oxidations, reductions, hydroxyl-
ations in different positions, isomerizations, and hydrolysis of the chain in C-17. 
Hydrocortisone (173) is an important anabolic, used clinically as anti-inflammatory 
and antiallergic drug, besides being a raw material for the synthesis of many 
steroid hormones. Biotransformation of 173 using Acremonium strictum generated 
the products 11β,17β-dihydroxyandrost-4-en-3-one (174, 8%), 11β,17α,20β,21-
tetrahydropregn-4-en-3-one (175, 11.2%), and 21-acetoxy-17β,17α,20-
trihydroxypregn-4-en-3-one (176, 7.6%); it was observed that the actions of the 
said species were as the reduction, acetylation and degradation of the chain in C-17, 
without modification of the unsaturated ketone-α,β [89]. Biotransformation of 173 
using Gibberella fujikuroi yielded 11β-hydroxyandrost-4-en-3,17-dione (177, 41%), 
while B. subtilis and R. stolonifer yielded 175 (15%). The products 173 (45%) and 
3β,11β,17α,21-tetrahydroxy-5α-pregnan-20-one (178, 31%) were obtained from the 
bioconversion of 173 using Bacillus cereus (Figure 22) [90].
Figure 20. 
Biotransformation products of 3-hydroxy-1,3,5-(10)-trien-17-one (166).
Figure 21. 
Biotransformation products of prednisone (169).
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Incubation of 17β-methoxy-5α-androst-3-one (179) with Cephalosporium 
aphidicola produced 17β-methoxy-5α-androst-3β-ol (180) and 6β,11α-
dihydroxy-17β-methoxy-5α-androst-3-one (181); while the biotransformation 
of 17β-methoxyestra-4-en-3-one (182) using C. aphidicola produced a major 
metabolite 6β-hydroxy-17β-methoxyestra-4-en-3-one (183). Similarly, the micro-
biological transformation of 3β-methoxyandrost-5-en-17-one (184) gave a mixture 
of products: 7α-hydroxy-3β-methoxyandrost-5-en-17-one (185) and 7β-hydroxy-3β-
methoxyandrost-5-en-17-one (186) (Figure 23) [91].
In the literature, several species of fungi belonging to the genera Aspergillus, 
Fusarium, Mortierella, and Penicillium and capable of hydroxylating various steroids 
in C-15 have been described. For example, Jekkel et al. [92] described that more 
than 3000 fungi hydroxylate 13β-ethyl-4-gonene-3,17-dione (187) in C-15 posi-
tion, the genus being Fusarium, particularly F. nivale; the fungus preferentially 
hydroxylated 187 with an α orientation in C-15 (15α-hydroxy-13β-ethyl-4-gonene-
3,17-dione, 188, 77%) and C-7β (7β,15α-dihydroxy-13β-ethyl-4-gonene-3,17-
diona, 189). On the other hand, the biotransformation of 187 using Mortierella 
pusilla produced 188, 190 (10β-hydroxy-13β-ethyl-4-gonene-3,17-dione) and 191 
(6β-hydroxy-13β-ethyl-4-gonene-3,17-dione) (Figure 24).
The ethynodiol diacetate (192) is a synthetic derivative 1, used as an oral contra-
ceptive because it inhibits the ovulation process. The microbiological transforma-
tion of 192 using Cunninghamella elegans produced four hydroxylated compounds 
Figure 22. 
Biotransformation products of hydrocortisone (173).
Figure 23. 
Biotransformation products of 17β-methoxy-5α-androst-3-one (179).
Chemistry and Biological Activity of Steroids
18
characterized as: 17α-ethynylestr-4-en-3β,17β-diacetoxy-6α-ol (193, 0.5%), 
17α-etynylestr-4-en-3β,17β-diacetoxy-6β-ol (194, 1.0%), 17α-etynylestr-4-en-
3β,17β-diacetoxy-10β-ol (195, 0.5%), and 17α-ethynyl-17β-acetoxiestr-4-en-3-one 
(196, 1.4%) (Figure 25) [93].
Desogestrel (13-ethyl-17-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol, 
197) is an orally active third-generation contraceptive steroid drug. Conversion 





dihydroxy-3-one (201). Compounds 197 and 198 showed a potent growth inhibi-
tion against drug-resistant strains of S. aureus (Figure 26) [94].
The drugs mexrenone (202) and canrenone (203) are steroids with a spi-
ronolactone in C-17 and are potent antagonists of mineralocorticoids [95]. The 
biotransformation of 202 and 203 using a wide variety of microorganisms resulted 
in the production of monohydroxylated products in different positions, where 
Beauveria bassiana generated 11α-hydroxymexrenone (204, 67%) as the major 
product, while 12β-hydroxymexrenone (205, 50%) and 6β-hydroxymexrenone 
(206, 33%) were obtained using Mortierella isabellina. The dehydrogenation 
product (Δ1(2)-mexrenone, 207, 15%) was favored with Bacterium cyclooxidants 
as well as Rhodococcus equi, Nocardia aurentia, and Comamonas testosteroni. From 
the biotransformation of 203 using Corynespora cassiicola, 9α-hydroxycanrenone 
Figure 25. 
Biotransformation products of ethynodiol diacetate (192).
Figure 24. 
Biotransformation products of 13β-ethyl-4-gonene-3, 17-dione (187).
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(208, 30%) was obtained, [96]. Conversion of canrenone (203) by Colletotrichum 
lini ST-1 gave two hydroxyl compounds, 15α-hydroxy-canrenone (209, 22%) and 
11α,15α-dihydroxy-canrenone (210, 47%) (Figure 27) [80].
One of the steroids used in the treatment of breast cancer is exemestane 
(211), an inhibitor of steroidal aromatase. From the transformation of 211 using 
Macrophomina phaseolina, 16β,17β-dihydroxy-6-methylene-androsta-1,4-diene-
3-one (212), 17β-hydroxy-6-methylene-androsta-1,4-diene-3,16-dione (213), and 
17β-hydroxy-6-methylene-androsta-1,4-diene-3-one (214) were obtained, while 
by using Fusarium lini, the only product obtained was 11α-hydroxy-6-methylene-
androsta-1,4-diene-3,17-dione (215) (Figure 28) [97].
4-Hydroxyandrost-4-ene-3,17-dione (formestane, 216) is an irreversible 
aromatase inhibitor and therapeutically used in breast cancer treatment in post-
menopausal women. Bioconversion of 216 using Rhizopus oryzae (ATCC 1145) 
resulted in the production of 4β,5α-dihydroxyandrost-3,17-dione (217, 8.6%) and 
3,5α-dihydroxyandrost-2-ene-4,17-dione (218) [98], while the biotransformation 
of 217 using Beauveria bassiana produced 4,17β-dihydroxyandrost-4-en-3-one 
(219, 5.3%), 3α,17β-dihydroxy-5β-androstan-4-one (220, 0.9%), and 4,11α,17β-
trihydroxyandrost-4-en-3-one (221, 2.4%) (Figure 29) [99].
Methyltestosterone (222), an anabolic steroid, was transformed 
by Mucor racemosus in 5 days to produce two monohydroxylated 
Figure 26. 
Biotransformation products of desogestrel (197).
Figure 27. 
Biotransformation products of mexrenone (202) and canrenone (203).
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products in the C-7 (7α-hydroxymethyltestosterone, 223, 35%) and C-15 
(15α-hydroxymethyltestosterone, 224, 21%) positions, plus a dihydroxylated product 
(12,15α-dihydroxymethyltestosterone, 225, 22%) [100]. Recently, three additional 
products were identified: 11α-hydroxy-17α-methyltestosterone (226), 6β-hydroxy-
17α-methyltestosterone (227), and 6β,11α-dihydroxy-17α-methyltestosterone (228). 
Isolation of hydroxylation products have been reported in different carbons from 222 
with different orientations, C-6β, C-7β, C-9α, C-11α, C-12β, and C-15α (Figure 30).
Dianabol (methandrostenolone, 17α-methyl-17β-hydroxyl-androst-1,4-dien-
3-on, 229) is an oral anabolic steroid that promotes the synthesis of proteins (increas-
ing the muscle tissue). From the biotransformation of 229 using Cunninghamella 
elegans, five bioconversion products were obtained: 6β-hydroxydianabol (230), 
15α-hydroxydianabol (231), 11α-hydroxydianabol (232), 6β,12β-dihydroxydianabol 
(233), and 6β,15α-dihydroxydianabol (234). The products 17β-hydroxy-17α-
methyl-5α-androst-1,4-dien-3,6-dione (235), 7β-hydroxydianabol (236), 
15β-hydroxydianabol (237), 17β-hydroxy-17α-methyl-5α-androst-1,4-dien-3,11-dione 
Figure 29. 
Biotransformation products of formestane (216).
Figure 28. 
Biotransformation products of exemestane (211).
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(238), and 11β-hydroxydianabol (239) were obtained from the biotransforma-
tion of 229 using Macrophomina phaseolina [101]. Biotransformation of 229 using 
several microorganisms has been reported, for example, Penicillium notatum [102] 
transformed 229 into 230 and 231, while Trichoderma hamatum produced 232 [103]. 
Figure 30. 
Biotransformation products of methyltestosterone (222).
Figure 31. 
Biotransformation products of dianabol (229).
Figure 32. 
Biotransformation products of masthasterone (241).
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Similarly, B. bassiana, A. ochraceus, Colletotrichum lagenarium, and Sporotrichum 
sulfurreducens gave a biotransformed product 232 [104]. Absidia glauca metabolized 
229 in compounds 230, and 236–237 [105]. In contrast, the biotransformation of 229 
using A. coerula yielded 239 along with 7α-hydroxydianabol (240) [106], while by 
using B cinerea, 237 was obtained as the only product (Figure 31) [107].
Methasterone (241) is a synthetic anabolic steroid, known to gain muscle 
mass. Microbial transformation of 241 using M phaseolina yielded 17β-hydroxy-
17α(hydroxymethyl)-2α-methyl-5α-androstane-3,6-dione (242), while by using C. 
blakesleeana, 7α-hydroxymethasterone (243, 2.0%), 7α,16β-dihydroxymethasterone 
(244, 0.7%), 5α,12β-dihydroxymethasterone (245, 1.0%), 7α,12β-
dihydroxymethasterone (246, 1.5%), and 7α,9α-dihydroxy-methasterone (247, 0.5%) 
were obtained. Incubation of 241 with Fusarium lini yielded different metabolites with 
dehydrogenation in ring A and D: 6β,17β-dihydroxy-2,17α-dimethyl-5α-androst-1,4-
diene-3-one (248, 1.0%), 15α,17β-dihydroxy-2α,17α-dimethyl-5α-androst-1,4-diene-
3-one (249, 0.6%), 6β,17β-dihydroxy-2,17α-dimethylandrost-1,4-diene-3-one (250, 
0.4%), 14α,15α-dihydroxy-2,17-dimethyl-5α-androst-1,4,16-trien-3-one (251, 0.3%), 
17β-hydroxy-2,17α-dimethyl-5α-androst-5α-1,4-dien-3,6-dione (252, 0.3%), and 
17β-hydroxy-2,17α-dimethyl-5α-androst-1,4-dien-3-one (253, 1.0%) (Figure 32) [108].
3. Conclusions
The biotransformation processes of different steroid compounds described in 
this review, although not exhaustive, aim to highlight the importance of biotrans-
formation through different microorganisms, as a useful chemical-biological tool 
for obtaining novel derivatives for research purpose and as industrial applica-
tions. An example includes obtaining steroid compounds for the pharmaceutical 
industry.
Biotransformation of steroids has been implemented in an important way in the 
partial synthesis of new steroids, for their evaluation as hormones and drugs. Currently, 
there is a wide variety of steroids used as diuretics, anabolic, anti-inflammatory, 
antiandrogenic, anticontraceptive, antitumor, among other applications. Chemical 
functionalization in different carbon atoms of the sternum skeleton is related to the 
biological activity of the molecule. This is why microbiological transformations play 
an important role in obtaining these compounds through chemical transformations, 
such as the oxidation of hydroxyl group at C-3 and C-17, isomerization of the double 
bond Δ5(6) to Δ4(5), hydrogenation of double bonds Δ1(2) and Δ4(5), and reduction of the 
carbonyl group at C-17 and C-20 with β orientation. Biohydroxylations performed in 
different positions of the steroid skeleton—C-11α, C-11β, C-15β, and C-16α—using dif-
ferent species of fungi of the genera Rhizopus, Aspergillus, Curvularia, Cunninghamella, 
and Streptomyces with high yields are an important chemical transformation in many 
synthesis schemes of new steroids with a determined biological activity.
Hydroxylation of steroids—progesterone, testosterone, 17α-methyltestosterone, 
and 4-androsten-3,17-dione—presenting the 4-en-3-one system, proceeds with a 
high stereo- and regioselectivity in the C-6 and C-11 positions, with a β orienta-
tion in C-6 and α orientation in C-11. The presence of the methyl group in C-10 
is necessary for the hydroxylation in C-11, as can be seen in the derivatives of 
19-nortesterone.
The interest in the biotransformation of steroid compounds has been increasing 
in recent years, due to the obtaining of new and useful pharmacologically active 
compounds. In addition to the development of new genetically modified strains, 
there is an increase in the availability of immobilized enzymes and the manipula-
tion of culture media.
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Biotransformation of steroids proceeds with low to moderate yields in general. 
One of the main causes is their low solubility in water. Currently, methodologies 
are developed that allow the incorporation of chemicals—surfactants, ionic liquids, 
cyclodextrins, liposomes, among others—that contribute to improve the yields of 
each biotransformation process and the processes friendly to the environment.
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